CLINICAL_TRIALS
trial_result
· 2019-03-01
Clinical Trial Update: Pembrolizumab in Treating Patients With Advanced Merkel Cell Cancer [Phase 2]
Summary
Phase 2 clinical trial of pembrolizumab in advanced Merkel cell carcinoma completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Merkel Cell Carcinoma, Stage III Merkel Cell Carcinoma AJCC v7 | Phase 2 | Status: COMPLETED | Results posted: 2019-03-01